معرفی
Yoshiaki Yasumizu is an Associate Research Scientist in the Department of Neurology at Yale School of Medicine, specializing in neuroimmunology and autoimmune disease mechanisms. His primary affiliation is with the David Hafler Laboratory within Yale's Neuroimmunology Lab, focusing on T-cell biology and transcriptomic analyses of autoimmune conditions.
His research centers on autoimmune diseases including multiple sclerosis, myasthenia gravis, and neuromyelitis optica spectrum disorders. Key methodologies involve single-cell RNA sequencing, transcriptomic profiling, and computational analysis of immune cell populations. Major contributions include identifying disease-specific gene expression patterns in thymoma, characterizing T-cell subsets in autoimmune conditions, and developing viral analysis pipelines from RNA-seq data.
Analysis of his 15 most recent publications reveals strong emphasis on immune cell dynamics following therapeutic interventions (particularly B-cell depletion), spatial organization of autoimmune responses in thymic tissue, and molecular mechanisms linking genetic variants to autoimmune susceptibility. His work bridges computational biology with experimental immunology, frequently employing multi-omics approaches to dissect disease pathogenesis.
Yasumizu collaborates extensively within the Hafler Lab network, with frequent co-authorship with David Hafler, Erin Longbrake, Khadir Raddassi, Le Zhang, and M. Elizabeth Deerhake. His research is supported through Yale's Department of Neurology infrastructure and NIH-funded initiatives within the Neuroimmunology program.
His technical expertise spans advanced genomic techniques including single-cell transcriptomics, epigenomic analysis, and bioinformatics pipeline development. Current work focuses on translating transcriptomic signatures into clinically actionable biomarkers for autoimmune disease monitoring and treatment response prediction.
